Cyclobutyl purine derivative or salt thereof
US12202850B2 · kind B2 · utility
0Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2023 |
| Grant date | Jan 21, 2025 |
| Priority date | — |
| Expiry date | Apr 5, 2043 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An object of the present invention is to provide a compound exhibiting an excellent drug efficacy as an anti-adenoviral agent, and an anti-adenoviral agent. The present invention provides a compound represented by General Formula [1]
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.